Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
When complete, the campus will house nearly 500,000 sq. ft. of space dedicated to the manufacturing, packaging and distribution of pharmaceuticals.
February 26, 2024
By: Kristin Brooks
Managing Editor, Contract Pharma
The Ritedose Corp. announced a multi-phased expansion project totaling more than $81 million over four years. The company recently purchased 105 acres from the Midlands Technical College Enterprise Campus in Richland Northeast, SC. Scheduled to break ground in the coming weeks, the company is renaming the new property Ritedose Performance Park. When complete, the campus will house nearly 500,000 sq. ft. of space dedicated to the manufacturing, packaging and distribution of pharmaceuticals. The Ritedose Corp. produces sterile, single-dose medication, serving the contract development manufacturing, generics and 503B outsourcing markets. The company’s customers range from small startups and retail pharmacies to large pharmaceutical companies, wholesalers and hospital systems. The first building on the newly acquired property will be a 225,000 sq.-ft. central distribution and logistics center. The land is contiguous to the Carolina Research Park off Farrow Road in Richland County, home to Ritedose’s corporate headquarters and manufacturing facility at 1 Technology Circle. “There continues to be a nationwide surge in demand for the medications we produce — especially for respiratory diseases. The volume of medications we’re producing has surpassed 1.5 billion doses annually, and we expect to produce more than 2 billion doses annually in the coming years,” said Ritedose President and CEO Jody Chastain. “Our production of ophthalmic medications has also rapidly increased due to demand from cutting edge ophthalmic drug developers. I’m incredibly proud of our team for working hard and smart to meet the needs of millions of patients across the United States and doing it with absolute integrity and excellence.” The addition of the facility will add more than 100 jobs to Ritedose’s growing workforce of more than 550 employees.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !